• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SPECTRANETICS STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON; DCB PTA CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SPECTRANETICS STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON; DCB PTA CATHETER Back to Search Results
Model Number A35DC06004013IO
Device Problem Insufficient Information (3190)
Patient Problems Pulmonary Embolism (1498); Death (1802)
Event Date 05/11/2015
Event Type  Death  
Manufacturer Narrative
The patient's death was unrelated to the stellarex device or procedure.The patient's death was unrelated to the stellarex device or procedure, thus the paclitaxel drug did not cause or contribute to the patient¿s death.Udi and pma numbers are not applicable.This device was used in clinical application prior to being available in the us.Foreign- belgium / study name: illumenate global, patient id #(b)(6).Combination product is applicable.During the index procedure, the product worked as intended, thus no product evaluation was required.Per the ifu, death is listed as a potential complications/adverse events.
 
Event Description
On (b)(6) 2015, the patient underwent an index procedure to treat a 120 mm, 80% stenotic denovo lesion in the right distal sfa.The lesion was predilated using a 5 x 80 mm balloon inflated to 8 atm, with a residual stenosis of 10%.Next, a 6 x 120 mm stellarex balloon was inflated to 7 atm for 3 minutes, resulting in 0% stenosis.Then, a 6 x 40 mm stellarex balloon was inflated to 6 atm for 3 minutes, with 0% residual stenosis.No complications occurred and the patient was discharged to go home the following day.The subject completed all required study followup visits through 12 months with the last visit occurring (b)(6) 2016.On (b)(6) 2017, the site became aware that the patient had died (b)(6) 2017.The patient was admitted on (b)(6) 2017.The patient had extensive pulmonary emboli associated with a lung tumor with no treatment options.Initially, the patient was in a relatively good condition as long as oxygen was administered.On (b)(6) 2017, there was a significant respiratory deterioration, for which subcutaneous morphine was administered.The patient died the following day, in the presence of his family.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON
Type of Device
DCB PTA CATHETER
Manufacturer (Section D)
SPECTRANETICS
fremont CA
Manufacturer (Section G)
SPECTRANETICS
6531 dumbarton circle
fremont CA 94555
Manufacturer Contact
florie cazem
5055 brandin court
fremont, CA 94538
510933-792
MDR Report Key6822970
MDR Text Key83728464
Report Number3009784280-2017-00016
Device Sequence Number1
Product Code ONU
Combination Product (y/n)N
Reporter Country CodeBE
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,study
Reporter Occupation Physician
Type of Report Initial
Report Date 08/07/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/22/2015
Device Model NumberA35DC06004013IO
Device Catalogue NumberA35DC06004013IO
Device Lot Number14M1760402
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/07/2017
Initial Date FDA Received08/25/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/24/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age68 YR
Patient Weight94
-
-